TegoScience Inc (191420) fair value: what the stock is really worth
As of Nov 19, 2026: fair value (intrinsic value) of TegoScience Inc stock KRW 5,634, price KRW 6,440, that is 12.5% below the price, quality 34 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
TegoScience Inc
191420 · KQExpensive (fair value 13% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range 5,600 KRW – 29,900 KRW · fair‑value band 4,225 KRW – 7,042 KRW · the 6,440 KRW price screens above the 5,634 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether TegoScience is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
TegoScience Inc. produces and sells wound-healing skin cell therapy products from human epithelial cells in South Korea. The company's products include Holoderm, Kaloderm, and Rosmir. It also provides Neoderm, contract research, and Skinbank services.
Show moreShow less
The company was founded in 2001 and is based in Seoul, South Korea.
Stock analysis
TegoScience Inc (191420) currently trades at 6,440 KRW, while our estimate is 5,634 KRW, 13% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: 4,225 KRW (bear) to 7,042 KRW (bull), the price of 6,440 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 34/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
TegoScience Inc reported revenue of 5.9B KRW in FY2025 versus 8.3B KRW in FY2021, a compound −8.0%/yr. Reported net income was −7.0B KRW in FY2025.
Key figures
Market cap 50.6B KRW (≈ $38.1M) Micro · P/S ratio 6.78 · Net margin 16.0% · Return on equity 705% · Return on assets (EBIT) −2.9% (5-year average) · Operating margin 13.1% · Revenue (TTM) 8.4B KRW · Revenue growth (YoY) +4.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 37 out of 100 (medium confidence).
What moves the price
The share trades about 65% below its 52-week high and 15% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −34% fair-value upside, at −13%, 191420 screens cheaper than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
191420 screens overvalued: fair value 13% below the price. Compare with ST Pharm Co →
Compare TegoScience Inc with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceuticals · 57 stocks
Valuation Multiplesvs Pharmaceuticals median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on equity by industry
- Quality Score by industry
- Stock screener with 62 metrics
- Undervalued stocks: South Korean Stocks
- Valuation of the Korea market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Pharmaceuticals stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Huons Global Co 084110 | 19,530 KRW | 47,019 KRW | +141% | vs 191420 |
| DongKook Pharmaceutical Co 086450 | 26,700 KRW | 28,372 KRW | +6% | vs 191420 |
| ST Pharm Co 237690 | 75,000 KRW | 61,182 KRW | −18% | vs 191420 |
| Vivozon Pharmaceutical Co 082800 | 2,800 KRW | 2,179 KRW | −22% | vs 191420 |
| Oscotec Inc 039200 | 32,400 KRW | 21,262 KRW | −34% | vs 191420 |
| NatureCell Co 007390 | 21,300 KRW | 11,176 KRW | −48% | vs 191420 |
| Mezzion Pharma Co 140410 | 61,700 KRW | 31,450 KRW | −49% | vs 191420 |
| BINEX Co 053030 | 7,010 KRW | 1,844 KRW | −74% | vs 191420 |
| Caregen Co 214370 | 28,050 KRW | 5,414 KRW | −81% | vs 191420 |
| SHUKRAPHAR SHUKRAPHAR | ₹82.22 | ₹9.14 | −89% | vs 191420 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is TegoScience Inc (191420) overvalued or undervalued?
What is the fair value of 191420?
What is the quality score of 191420?
What is the price target for TegoScience Inc (191420)?
What is the TegoScience Inc stock forecast for 2026?
What is the revenue of TegoScience Inc (191420)?
What is the intrinsic value of TegoScience Inc (191420)?
Is TegoScience Inc stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 191420?
How much is TegoScience Inc worth?
What do the bullish and bearish scenarios say about 191420?
How solid is the balance sheet of TegoScience Inc (191420)?
How far is 191420 from its 52-week high?
Which stocks are comparable to TegoScience Inc?
Is TegoScience Inc stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of TegoScience Inc (191420)?
What should I pay attention to with TegoScience Inc right now?
Key figures of TegoScience Inc
How large is the market capitalisation of TegoScience Inc (191420)?
What is the P/S ratio of TegoScience Inc (191420)?
What is the net margin of TegoScience Inc (191420)?
What is the return on equity of TegoScience Inc (191420)?
What is the EBIT return on assets of TegoScience Inc (191420)?
What is the operating margin of TegoScience Inc (191420)?
How fast is revenue growing at TegoScience Inc (191420)?
How fast are earnings growing at TegoScience Inc (191420)?
How much free cash flow does TegoScience Inc (191420) generate?
How much net debt does TegoScience Inc (191420) carry?
Watch TegoScience Inc in the live analysis
One click puts TegoScience Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.